BELITE BIO, INC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.93 USD | +2.97% |
|
+18.71% | -10.54% |
| 26/04 | Belite Bio Unveils Plan to Offer 651,380 American Depository Shares | MT |
| 22/03 | Belite Bio Completes Regulatory Submission for Tinlarebant's Clinical Trial in Japan | MT |
Chart calendar Belite Bio, Inc
cf8930482010136134afd480bffc.G_CCtuTKsz4o6AcnaGaSwnnSlAKAT5_r-uAgSHkjrLU.Lpfx8pe4330ZnGMUEjLTqA2l10baAcifkZdLAU5sz88ru8PHp5rpDx2-Mw~c34ce69b837e135f0b375061dd8e056a
Upcoming events on Belite Bio, Inc
Past events on Belite Bio, Inc
| 13/03/2024 07:30 pm | Leerink Partners Global Biopharma Conference |
| 13/03/2024 02:00 am | Q4 2023 Earnings Call |
| 12/03/2024 06:57 am | Q4 2023 Earnings Release |
| 14/02/2024 11:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 07/12/2023 | Benchmark Company Discovery Conference |
| 28/11/2023 01:30 am | BTIG Ophthalmology Day |
| 15/11/2023 03:00 am | Q3 2023 Earnings Call |
| 14/11/2023 06:45 am | Q3 2023 Earnings Release |
| 08/11/2023 09:30 pm | Deutsche Bank Depositary Receipts Virtual Investor Conference |
| 06/11/2023 05:27 am | American Academy Of Ophthalmology Meeting |
| 26/09/2023 | Cantor Global Healthcare Conference |
| 14/09/2023 | H.C. Wainwright Global Investment Conference |
| 10/08/2023 02:00 am | Q2 2023 Earnings Call |
| 09/08/2023 07:47 am | Q2 2023 Earnings Release |
| 11/05/2023 05:30 pm | Q1 2023 Earnings Call |
| 10/05/2023 | Q1 2023 Earnings Release |
| 03/05/2023 10:30 pm | Investor Meeting - Key Opinion Leader |
| 25/04/2023 07:15 pm | Association for Research in Vision and Ophthalmology Meeting |
| 04/04/2023 02:00 am | Q4 2022 Earnings Call |
| 01/04/2023 04:33 am | Q4 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 10,0 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -12,8 -13,5 5.27% | -31,7 -32,1 1.4% | -29,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -12,6 -13,4 5.88% | -31,6 -32,1 1.34% | -29,5 |
|
Net income Million USD | Released Forecast Spread | -9,67 | -12,6 -13,4 5.88% | -31,6 -32,8 3.64% | -22,9 |
|
EPS USD | Released Forecast Spread | -1,01 | -0,63 -0,66 3.82% | -1,19 -1,29 7.61% | -0,77 |
| Announcement Date | 15/03/22 | 31/03/23 | 12/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 12,5 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,78 -4,03 55.78% | -1,78 -4,73 62.33% | -4,35 | -5,63 | -6,88 -5,02 -37.07% | -6,87 -7,41 7.32% | -11,0 -8,38 -30.8% | -6,98 -7,43 6.1% | -7,50 | -7,07 | -7,57 | -6,90 | -6,50 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,89 -5,02 -37.22% | -6,81 -7,41 8.16% | -10,9 -8,38 -30.47% | -6,99 -7,43 5.89% | -7,50 | -7,07 | -7,57 | -6,90 | -6,50 |
|
Net income Million USD | Released Forecast Spread | -1,73 -4,03 57.02% | -1,73 -4,73 63.39% | -4,35 | -5,63 | -6,90 -5,02 -37.34% | -6,81 -7,44 8.38% | -10,9 -8,79 -24.47% | -6,99 -8,20 14.78% | -8,45 | -8,20 | -8,60 | 4,32 | -6,50 |
|
EPS USD | Released Forecast Spread | -0,12 -0,29 57.89% | -0,12 -0,24 48.94% | -0,18 | -0,23 | -0,33 -0,20 -65% | -0,26 -0,30 12.61% | -0,40 -0,32 -25% | -0,24 -0,30 20% | -0,29 | -0,28 | -0,29 | 0,16 | -0,20 |
| Announcement Date | 11/08/22 | 11/08/22 | - | - | 10/05/23 | 09/08/23 | 14/11/23 | 12/03/24 | - | - | - | - | - |
| 01/05/2024 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 01/05/2024 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 01/05/2024 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 01/05/2024 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
Past sector events for Belite Bio, Inc
| Today | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 01:35 am | QIAGEN N.V.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 29/04/2024 | SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release |
| 29/04/2024 | JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | MORPHOSYS AG: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- BLTE Stock
- Calendar Belite Bio, Inc
